FDA.reportPublic FDA data

Lotemax 0.5 % Ophthalmic Ointment

RxCUI
1099503
RxNorm name
Lotemax 0.5 % Ophthalmic Ointment
Display name
Lotemax 0.5 % Ophthalmic Ointment
Full name
Lotemax 0.5 % Ophthalmic Ointment
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:08

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LotemaxLOTEPREDNOL ETABONATEBausch & Lomb Incorporated902a3c6b-2625-44ec-a077-926e012b31762022-11-30Warnings, Adverse reactionsExact identifier
rxcui: 1099503

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
902a3c6b-2625-44ec-a077-926e012b3176LOTEMAX 0.5 % Ophthalmic Ointment [PSN] · loteprednol etabonate 0.005 MG/MG Ophthalmic Ointment [Lotemax] [SBD] · Lotemax 0.005 MG/MG Ophthalmic Ointment [SY] · Lotemax 0.5 % Ophthalmic Ointment [SY]417These highlights do not include all the information needed to use LOTEMAX ointment safely and effectively. See full prescribing information for LOTEMAX ointment. LOTEMAX ® (loteprednol etabonate ophthalmic ointment) 0.5%, for topical ophthalmic use Initial U.S. Approval: 199820221130